PR Newswire INCHEON, South Korea, Dec. 1, 2025 INCHEON, South Korea, Dec. 1, 2025 /PRNewswire/ -- Celltrion, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO® (omalizumab-igec), the ...
PR Newswire TOKYO and CAMBRIDGE, Mass., Dec. 2, 2025 TOKYO and CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...
PR Newswire ARLINGTON, Va. and BETHESDA, Md. and CHICAGO and DALLAS, Dec. 1, 2025 During National Influenza Vaccination Week, experts encourage everyone 6 months and older to get vaccinated to reduce risk of severe illness and ...
PR Newswire HONG KONG, Nov. 30, 2025 -Â Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than ...
PR Newswire SAN FRANCISCO and SUZHOU, China, Nov. 25, 2025 SAN FRANCISCO and SUZHOU, China, Nov. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...
PR Newswire KEELE, England, Nov. 25, 2025 STIMULAN® Rapid Cure can now be used with both a wider range of antibiotics and also with antifungals in India STIMULAN® Rapid Cure can be placed in bone and surrounding soft tissue to assist in ...
PR Newswire EAST HANOVER, N.J., Nov. 24, 2025 EAST HANOVER, N.J., Nov. 24, 2025 /PRNewswire/ -- Novartis today announced that the US Food and Drug Administration (FDA) has approved Itvisma® (onasemnogene abeparvovec-brve) for the treatment ...
PR Newswire ARLINGTON, Va., Nov. 20, 2025 ARLINGTON, Va., Nov. 20, 2025 /PRNewswire/ -- ASTHO Chief Medical Officer Susan Kansagra, MD, MBA made the following statement regarding vaccines and autism: "As public health professionals, ...
PR Newswire AUSTIN, Texas, Nov. 18, 2025 AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its ...
PR Newswire CAMBRIDGE, Mass. and SINGAPORE, Nov. 18, 2025 CAMBRIDGE, Mass. and SINGAPORE, Nov. 18, 2025 /PRNewswire/ -- Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency ...
Researchers found that using mental models—visual, verbal, or animated—helps people understand mRNA vaccination science, counter misconceptions, and reduce misinformation spread.
Children with eczema may gain protection from COVID-19 vaccination, showing lower risks of infections and allergic complications, including asthma and skin conditions.
Diabetic drugs (GLP-1 drugs – Glucagon-Like Peptide-1) may provide equal better protection for the kidneys and heart in military retirees with type 2 diabetes.
A rigorous review shows acetaminophen (paracetamol) use during pregnancy is not linked to autism or ADHD, offering reassurance for expectant mothers and healthcare provider
Cobenfy, the first new schizophrenia drug in 50 years, offers early insights that could pave the way for more personalized psychosis treatment.
MEDINDIA
English
हिन्दी
Español
français
中文